FratFiles

• Save Paper

Imperatives for the Indian pharmaceutical industry in a changing world
|[pic] |
|K V Subramaniam |
|President and CEO |
|Reliance Life Sciences |

The Indian pharmaceutical industry can look forward to the New Year, as well as to the years to come, with great expectations. There are opportunities galore—in enlarging the reach of competitive generics as more people enjoy economic prosperity around the world; in expanding the range of generic products as more molecules come off patent; and, above all, in enhancing the value footprint into discovery as more profits come from traditional plays.
At the same time, the Indian pharma industry would have to contend with several challenges—in making generics more affordable so as to address the bottom of the affordability pyramid in a context of rising prices; in maneuvering increasingly protective innovator companies coming to terms with low research productivity and......

View the rest of this paper...

Approximate Word Count: 6429
Approximate Pages: 26 (250 words per double-spaced page)

Similar Essays

1. Organised Pharma Retail In India
   

   Organised Pharma Retail in India Executive summary The retailing arena in India has historically been dominated by traditional formats and only 2% of retail flows through

2. Pharma
   

   Pharma Imperatives for the Indian pharmaceutical industry in a changing world |[pic] | |K V Subramaniam | |President and CEO | |Reliance Life Sciences | The Indian pharmaceutical

3. Indian Pharma Industry
   

   indian pharma industry STRATEGIC MANAGEMENT PROJECT ON PHARMACEUTICAL INDUSTRY Management Development Institute Gurgaon Submitted to Prof. Amit Kapoor Submitted By: Anish Agarwal

4. Working For Pharma Inc
   

   Working for Pharma Inc Working for Pharma, Inc. I. Company background and revealed facts • A major pharmaceutical company that sold $8.9 billion of drugs all over the world in

5. Pharma
   

   Pharma 1. Industry - At Present Globally, the output of Indian pharmaceutical industry ranks 4th in terms of volume and 13th in terms of value. In FY02, the domestic Indian pharma